PUBLIC COMPANY
save$RNACCartesian Therapeutics, Inc.
$RNACFrederick, MD, USupdated 13d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Descartes-08 in Autoantibody Myositis
- phase2Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- phase2Descartes-08 for Patients With Systemic Lupus Erythematosus
- phase3Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
- phase1Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
- phase2Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
- phase1Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma
- phase2Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
Insider activity
source: SEC Form 4routine RSU / option mechanics (5)
- Apr 2, 26option exerciseHoge Elizabeth · 10% owner758,001 sh
- Apr 2, 26option exerciseHoge Elizabeth · 10% owner22,740 sh
- Apr 2, 26option exerciseKalayoglu Murat · 10% owner758,001 sh
- Apr 2, 26option exerciseKalayoglu Murat · 10% owner22,740 sh
- Mar 13, 26giftSinger Michael · director6,555 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that